Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
bretyliumtosylat 500 mg/10 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
bretyliumtosylat 500 mg/10 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
efedrinhydroklorid 30 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
efedrinhydroklorid 30 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
dopaminhydroklorid 400 mg/10 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dopaminhydroklorid 400 mg/10 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 12,5 mg/0,5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 12,5 mg/0,5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
bumetanid 2 mg/4 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
bumetanid 2 mg/4 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
dopaminhydroklorid 200 mg/5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
dopaminhydroklorid 200 mg/5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 250 mg/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 250 mg/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
efedrinhydroklorid 30 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
efedrinhydroklorid 30 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
dopexaminhydroklorid 50 mg/5 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
dopexaminhydroklorid 50 mg/5 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
etanolaminoleat 100 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
etanolaminoleat 100 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 25 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 25 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
bupivakainhydroklorid 50 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
bupivakainhydroklorid 50 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
doxapramhydroklorid 100 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
doxapramhydroklorid 100 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 25 mg/ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 25 mg/ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
bupivakainhydroklorid 312,5 mg/250 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
bupivakainhydroklorid 312,5 mg/250 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
doxorubicinhydroklorid 200 mg/100 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
doxorubicinhydroklorid 200 mg/100 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 50 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 50 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
buprenorfin (som buprenorfinhydroklorid) 300 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
buprenorfin (som buprenorfinhydroklorid) 300 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
ekulizumab 300 mg/30 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
ekulizumab 300 mg/30 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 50 mg/2 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
flufenazindekanoat 50 mg/2 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
buserelin (som buserelinacetat) 5,5 mg/5,5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
buserelin (som buserelinacetat) 5,5 mg/5,5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
edrofoniumklorid 150 mg/15 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
edrofoniumklorid 150 mg/15 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fondaparinuxnatrium 5 mg/0,4 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fondaparinuxnatrium 5 mg/0,4 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
kalcitriol 1 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
kalcitriol 1 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
Dinoprostone 400 microgram/mL vaginal gel |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
kalcitriol 2 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
kalcitriol 2 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 1 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 1 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
enoxaparinnatrium 40 mg/0,4 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
enoxaparinnatrium 40 mg/0,4 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
fentanyl (som fentanylcitrat) 100 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fentanyl (som fentanylcitrat) 100 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
enoxaparinnatrium 60 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
enoxaparinnatrium 60 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
Product containing precisely dipyridamole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 5 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 5 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
enoxaparinnatrium 80 mg/0,8 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
enoxaparinnatrium 80 mg/0,8 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
flekainidacetat 150 mg/15 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
flekainidacetat 150 mg/15 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cefuroxim (som natriumcefuroxim) 1,5 g/50 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cefuroxim (som natriumcefuroxim) 1,5 g/50 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
certoparinnatrium 3 000 enheter/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
certoparinnatrium 3 000 enheter/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 5 mg/5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 5 mg/5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
klorpromazinhydroklorid 50 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
klorpromazinhydroklorid 50 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
Methadone hydrochloride 400 microgram/mL oral solution |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
2 |
koriogonadotropin alfa 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
koriogonadotropin alfa 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
bupivakainhydroklorid 25 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
bupivakainhydroklorid 25 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epirubicinhydroklorid 200 mg/100 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epirubicinhydroklorid 200 mg/100 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
klonidinhydroklorid 150 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
klonidinhydroklorid 150 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cidofovir 375 mg/5 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cidofovir 375 mg/5 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
karboprost (som karboprosttrometamin) 250 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
karboprost (som karboprosttrometamin) 250 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dinoproston 750 mikrogram/0,75 ml, infusionsväska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dinoproston 750 mikrogram/0,75 ml, infusionsväska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cimetidin 200 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cimetidin 200 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epirubicinhydroklorid 10 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epirubicinhydroklorid 10 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 1 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 1 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
ciprofloxacin (som ciprofloxacinlaktat) 200 mg/100 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
ciprofloxacin (som ciprofloxacinlaktat) 200 mg/100 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |